142 related articles for article (PubMed ID: 29571260)
1. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
Yang G; Song R; Wang L; Wu X
Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
[TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
5. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H; Ma Y; Zhong D; Yang L
Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression.
Wang L; Liu Y
Cell Cycle; 2020 Jun; 19(12):1517-1529. PubMed ID: 32401134
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
9. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
11.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
12. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
Zhong X; Cai Y
Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
Gui D; Cao H
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
[TBL] [Abstract][Full Text] [Related]
15. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
Xu K; Feng Y
J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis.
Xia H; Jing H; Li Y; Lv X
Biomed Pharmacother; 2018 Oct; 106():156-162. PubMed ID: 29958139
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1.
Lu X; Qiao L; Liu Y
J Cell Biochem; 2020 Oct; 121(10):4064-4073. PubMed ID: 31930565
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.
Wang Z; Wang Z; Liu J; Yang H
Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
